Salivary hypofunction and xerostomia: Diagnosis and treatment

Dental Clinics of North America

Volumn 49, Issue 2, 2005, Pages 309-326

  Atkinson, Jane C ^a   Grisius, Margaret ^b   Massey, Ward ^c  

^a UNIVERSITY OF MARYLAND DENTAL SCHOOL   (United States)

^b NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

^c HARVARD SCHOOL OF DENTAL MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA INTERFERON; AMIFOSTINE; AMITRIPTYLINE; ANTIFUNGAL AGENT; ANTIHISTAMINIC AGENT; ANTIHYPERTENSIVE AGENT; ANTIINFLAMMATORY AGENT; CEVIMELINE; CHLORPROMAZINE; CHOLINERGIC RECEPTOR BLOCKING AGENT; CLOTRIMAZOLE; CYCLOSPORIN; DIURETIC AGENT; DONEPEZIL; IMMUNOSUPPRESSIVE AGENT; IPRATROPIUM BROMIDE; NEUROLEPTIC AGENT; NYSTATIN; OLANZAPINE; OPIATE; OXYBUTYNIN; PILOCARPINE; SALIVA SUBSTITUTE; SEDATIVE AGENT; SEROTONIN UPTAKE INHIBITOR; TRIAMCINOLONE; TRIAZOLAM; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG;

AGING; ALZHEIMER DISEASE; AUTOIMMUNE DISEASE; BRADYCARDIA; CANCER RADIOTHERAPY; CLINICAL FEATURE; CLINICAL TRIAL; DENTAL CARE; DENTAL CARIES; DEPRESSION; DISEASE ASSOCIATION; DRUG ANTAGONISM; DRUG CONTRAINDICATION; DRUG EFFECT; DRUG EFFICACY; DYSPHAGIA; ELECTROSTIMULATION; EPIDEMIOLOGICAL DATA; FLUID INTAKE; GASTROINTESTINAL SYMPTOM; HEART DISEASE; HUMAN; HUMIDITY; HYPERTENSION; HYPOSALIVATION; INCIDENCE; LUNG DISEASE; MOUTH INFECTION; MOUTHWASH; MUSCLE HYPERTONIA; MYCOSIS; POLYPHARMACY; PREVALENCE; RADIATION EXPOSURE; RADIATION INJURY; RESPIRATORY TRACT DISEASE; REVIEW; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; SIALOADENITIS; SIDE EFFECT; SJOEGREN SYNDROME; SWEATING; TACHYCARDIA; TRANSCUTANEOUS NERVE STIMULATION; TREATMENT PLANNING; VISUAL IMPAIRMENT; XEROSTOMIA;

EID: 14744301397     PISSN: 00118532     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cden.2004.10.002     Document Type: Review

References (89)

1. A. Van Nieuw Amerongen, J.G. Bolscher, and E.C. Veerman Salivary proteins: protective and diagnostic value in cariology? Caries Res 38 3 2004 247 251
2. A.M. Pedersen, A. Bardow, and S.B. Jensen Saliva and gastrointestinal functions of taste, mastication, swallowing and digestion Oral Dis 8 3 2002 117 129
3. A.S. Papas, A. Joshi, and S.L. MacDonald Caries prevalence in xerostomic individuals J Can Dent Assoc 59 2 1993 171 174 177-9
4. M. Kitamura, H.A. Kiyak, and K. Mulligan Predictors of root caries in the elderly Community Dent Oral Epidemiol 14 1 1986 34 38
5. D.J. Caplan, and R.J. Hunt Salivary flow and risk of tooth loss in an elderly population Community Dent Oral Epidemiol 24 1 1996 68 71
6. C.W. Leone, and F.G. Oppenheim Physical and chemical aspects of saliva as indicators of risk for dental caries in humans J Dent Educ 65 10 2001 1054 1062
7. Y. Kamagata-Kiyoura, S. Abe, and H. Yamaguchi Reduced activity of Candida detachment factors in the saliva of the elderly J Infect Chemother 10 1 2004 59 61
8. L. Radfar, Y. Shea, and S.H. Fischer Fungal load and candidiasis in Sjögren's syndrome Oral Surg Oral Med Oral Pathol Oral Radiol Endod 96 3 2003 283 287
9. Y.B. Wahlin Salivary secretion rate, yeast cells, and oral candidiasis in patients with acute leukemia Oral Surg Oral Med Oral Pathol 71 6 1991 689 695
10. M. Navazesh, G.J. Wood, and V.J. Brightman Relationship between salivary flow rates and Candida albicans counts Oral Surg Oral Med Oral Pathol Oral Radiol Endod 80 3 1995 284 288
11. J.D. Rudney, Z. Ji, and C.J. Larson The prediction of saliva swallowing frequency in humans from estimates of salivary flow rate and the volume of saliva swallowed Arch Oral Biol 40 6 1995 507 512
12. K. Ikebe, H. Sajima, and S. Kobayashi Association of salivary flow rate with oral function in a sample of community-dwelling older adults in Japan Oral Surg Oral Med Oral Pathol Oral Radiol Endod 94 2 2002 184 190
13. I.H. Valdez, and P.C. Fox Interactions of the salivary and gastrointestinal systems. I. The role of saliva in digestion Dig Dis 9 3 1991 125 132
14. W.J. Loesche, J. Bromberg, and M.S. Terpenning Xerostomia, xerogenic medications and food avoidances in selected geriatric groups J Am Geriatr Soc 43 4 1995 401 407
15. E.M. Ghezzi, L.A. Wagner-Lange, and M.A. Schork Longitudinal influence of age, menopause, hormone replacement therapy, and other medications on parotid flow rates in healthy women J Gerontol A Biol Sci Med Sci 55 1 2000 M34 M42
16. B.J. Baum Salivary gland fluid secretion during aging J Am Geriatr Soc 37 5 1989 453 458
17. L. Sreebny, A. Valdini, and A. Yu Xerostomia. Part II: Relationship to nonoral symptoms, drugs and diseases Oral Surg Oral Med Oral Pathol 68 4 1989 419 427
18. A.J. Wu, and J.A. Ship A characterization of major salivary gland flow rates in the presence of medications and systemic diseases Oral Surg Oral Med Oral Pathol Oral Radiol Endod 76 3 1993 301 306
19. M. Navazesh, V.J. Brightman, and J.M. Pogoda Relationship of medical status, medications, and salivary flow rates in adults of different ages Oral Surg Oral Med Oral Pathol Oral Radiol Endod 81 2 1996 172 176
20. D.W. Kaufman, J.P. Kelly, and L. Rosenberg Recent patterns of medication use in the ambulatory adult population of the United States: the Slone survey JAMA 287 3 2002 337 344
21. R. Bressler, and J.J. Bahl Principles of drug therapy for the elderly patient Mayo Clin Proc 78 12 2003 1564 1577
22. T. Linjakumpu, S. Hartikainen, and T. Klaukka Use of medications and polypharmacy are increasing among the elderly J Clin Epidemiol 55 2002 809 817
23. E.M. Ghezzi, and J.A. Ship Aging and secretory reserve capacity of major salivary glands J Dent Res 82 10 2003 844 848
24. A.J. Wu, B.J. Baum, and J.A. Ship Extended stimulated parotid and submandibular secretion in a healthy young and old population J Gerontol A Biol Sci Med Sci 50A 1995 M45 M48
25. I. Thorselius, C.G. Emilson, and T. Österberg Salivary conditions and drug consumption in older age groups of elderly Swedish individuals Gerodontics 4 2 1988 66 70
26. S.L. Handelman, J.M. Baric, and R.H. Saunders Hyposalivatory drug use, whole stimulated salivary flow, and mouth dryness in older, long-term care residents Spec Care Dentist 9 1 1989 12 18
27. H. Pajukoski, J.H. Meurman, and P. Halonen Prevalence of subjective dry mouth and burning mouth in hospitalized elderly patients and outpatients in relation to saliva, medication, and systemic diseases Oral Surg Oral Med Oral Pathol Oral Radiol Endod 92 6 2001 641 649
28. T. Österberg, S. Landahl, and B. Hedegård Salivary flow, saliva, pH and buffering capacity in 70-year-old men and women J Oral Rehab 11 2 1984 157 170
29. H. Ben-Aryeh, D. Miron, and I. Berdicevsky Xerostomia in the elderly: prevalence, diagnosis, complications and treatment Gerodontology 4 2 1985 77 82
30. G.H. Gilbert, M.W. Heft, and R.P. Duncan Mouth dryness as reported by older Floridians Community Dent Oral Epidemiol 21 6 1993 390 397
31. W.M. Thomson, J.M. Chalmers, and A.J. Spencer Medication and dry mouth: findings from a cohort study of older people J Public Health Dent 60 1 2000 12 20
32. D. Locker Xerostomia in older adults: a longitudinal study Gerodontology 12 1 1995 18 25
33. K.J. Bloch, W.W. Buchanan, and M.J. Wohl Sjögren's syndrome: a clinical, pathological and serological study of sixty-two cases Medicine (Baltimore) 44 1965 187 231
34. C. Vitali, S. Bombardieri, and R. Jonsson Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group Ann Rheum Dis 61 6 2002 554 558
35. U.G. Dafni, A.G. Tzioufas, and P. Staikos Prevalence of Sjögren's syndrome in a closed rural community Ann Rheum Dis 56 9 1997 521 525
36. T.E. Daniels Labial salivary gland biopsy in Sjögren's syndrome. Assessment as a diagnostic criterion in 362 suspected cases Arthritis Rheum 27 2 1984 147 156
37. F.N. Skopouli, U. Dafni, and J.P. Ioannidis Clinical evolution and morbidity and mortality of primary Sjögren's syndrome Semin Arthritis Rheum 29 5 2000 296 304
38. B. Strombeck, C. Ekdahl, and R. Manthorpe Health-related quality of life in primary Sjögren's syndrome, rheumatoid arthritis, and fibromyalgia compared to normal population using SF-36 Scand J Rheumatol 29 1 2000 20 28
39. S.T. Valtysdottir, B. Gudbjornsson, and U. Lindqvist Anxiety and depression in patients with primary Sjögren's syndrome J Rheumatol 27 1 2000 165 169
40. J.A. Ship, P.C. Fox, and J.E. Michalek Treatment of primary Sjögren's syndrome with low-dose natural human interferon-alpha administered by the oral mucosal route: a phase II clinical trial. IFN Protocol Study Group J Interferon Cytokine Res 19 8 1999 943 951
41. A. Vissink, F.R. Burlage, and F.K. Spijkervet Prevention and treatment of the consequences of head and neck radiotherapy Crit Rev Oral Biol Med 14 3 2003 213 225
42. M. Caglar, M. Tuncel, and R. Alpar Scintigraphic evaluation of salivary gland dysfunction in patients with thyroid cancer after radioiodine treatment Clin Nucl Med 27 11 2002 767 771
43. K.H. Rahn, M. van Baak, and M. van Hooff Studies on salivary flow in borderline hypertension J Hypertens Suppl 1 2 1983 77 78
44. C.F. Streckfus, A.J. Wu, and J.A. Ship Comparison of stimulated parotid salivary gland flow rates in normotensive and hypertensive persons Oral Surg Oral Med Oral Pathol 77 6 1994 615 619
45. T. Nederfors, and C. Dahlof Effects on salivary flow rate and composition of withdrawal of and re-exposure to the beta 1-selective antagonist metoprolol in a hypertensive patient population Eur J Oral Sci 104 3 1996 262 268
46. D.D. Gretler, G.P. Gramelspacher, and M.T. Fumo Influence of diuretic therapy on the clonidine suppression test J Clin Pharmacol 31 5 1991 448 454
47. E.M. Chavez, G.W. Taylor, and L.N. Borrell Salivary function and glycemic control in older persons with diabetes Oral Surg Oral Med Oral Pathol Oral Radiol Endod 89 3 2000 305 311
48. J.A. Ship, C. DeCarli, and R.P. Friedland Diminished submandibular salivary flow in dementia of the Alzheimer type J Gerontol 45 2 1990 M61 M66
49. G. Palmai, B. Blackwell, and A.E. Maxwell Patterns of salivary flow in depressive illness and during treatment Br J Psychiatry 113 1967 1297 1308
50. M.T. Brennan, G. Shariff, and P.B. Lockhart Treatment of xerostomia: a systematic review of therapeutic trials Dent Clin North Am 46 4 2002 847 856
51. A. Eisbruch, J.A. Ship, and L.A. Dawson Salivary gland sparing and improved target irradiation by conformal and intensity modulated irradiation of head and neck cancer World J Surg 27 7 2003 832 837
52. M.B. Parlimant, R.A. Scrimger, and S.G. Anderson Preservation of oral health-related quality of life and salivary flow rates after inverse-planned intensity-modulated radiotherapy (IMRT) for head and neck cancer Int J Radiat Oncol Biol Phys 58 3 2004 663 673
53. M. Mehta Amifostine and combined-modality therapeutic approaches Semin Oncol 26 2 1999 95 101
54. T. Wasserman Radioprotective effects of amifostine Semin Oncol 26 2 1999 34 36
55. S.E. Taylor, and E.G. Miller Preemptive pharmacologic intervention in radiation-induced salivary dysfunction Proc Soc Exp Biol Med 221 1 1999 14 26
56. D. Rades, F. Fehlauer, and A. Bajrovic Serious adverse effects of amifostine during radiotherapy in head and neck cancer patients Radiother Oncol 70 3 2004 261 264
57. F.M. Jacobsen, and L. Comas-Diaz Donepezil for psychotropic-induced memory loss J Clin Psychiatry 60 10 1999 497 504
58. K.D. Hunter, and W.S. Wilson The effects of antidepressant drugs on salivary flow and content of sodium and potassium ions in human parotid saliva Arch Oral Biol 40 11 1995 983 989
59. E. Trindade, D. Menon, and L.A. Topfer Adverse effects associated with selective serotonin reuptake inhibitors and tricyclic antidepressants. A meta analysis CMAJ 159 10 1998 1245 1252
60. R.R. Conley, C.A. Tamminga, and J.J. Bartko Olanzapine compared with chlorpromazine in treatment-resistant schizophrenia Am J Psychiatry 155 7 1998 914 920
61. M.B. Alves, A.C. Motta, and W.C. Messina Saliva substitute in xerostomic patients with primary Sjögren's syndrome: a single-blind trial Quintessence Int 35 5 2004 392 396
62. C. Van Loveren Sugar alcohols: what is the evidence for caries-preventive and caries-therapeutic effects? Caries Res 38 3 2004 286 293
63. D.L. Domingo The effects of electrostimulation on saliva production in postradiation head and neck cancer patients Oral Surg Oral Med Oral Pathol Oral Radiol Endod 97 4 2004 464
64. P.C. Fox, J.C. Atkinson, and A.A. Macynski Pilocarpine treatment of salivary gland hypofunction and dry mouth (xerostomia) Arch Intern Med 151 6 1991 1149 1152
65. J.C. Atkinson, and B.J. Baum Salivary enhancers J Dent Educ 65 10 2001 1096 1101
66. B. Gotrick, S. Akerman, and D. Ericson Oral pilocarpine for treatment of opiod-induced oral dryness in healthy adults J Dent Res 83 5 2004 393 397
67. A. Shiozawa Cevimeline hydrochloride hydrate (Saligren capsules 30 mg): a review of its pharmacologic profiles and clinical potential in xerostomia Nippon Yakurigaku Zasshi 120 4 2002 253 258
68. R.I. Fox Cevimeline, a muscarinic M1 and M3 agonist, in the treatment of Sjögren's syndrome Adv Exp Med Biol 506 Pt B 2002 1107 1116
69. J.C. Atkinson, and A.J. Wu Salivary gland dysfunction: causes, symptoms and treatment J Am Dent Assoc 125 1994 409 416
70. M.F. Jensen, and F. Kohout The effect of a fluoride dentifrice on root and coronal caries in an older population J Am Dent Assoc 117 1988 829 832
71. J.D.B. Featherstone Fluoride, remineralization and root caries Am J Dent 7 1994 279
72. C.N. Haveman, and S.W. Redding Dental management and treatment of xerostomic patients Tex Dent J 115 1998 43 56
73. J.O. Burgess, B. Norling, and J. Ong Directly placed esthetic restorative materials Compend Contin Educ Dent 17 1996 731 748
74. F. Rezk-Lega, B. Ogaard, and G. Rolla Availability of fluoride from glass ionomer luting cements in human saliva Scand J Dent Res 99 1991 60 63
75. E.M. Benelli, M.C. Serra, and A.L. Rodrigues Jr. In-situ anti-cariogenic potential of glass-ionomer cement Caries Res 27 1993 280 284
76. M.J. Tyas Cariostatic effect of glass-ionomer cement - a 5 year study Aust Dent J 36 1991 236 239
77. X. Xu, J.O. Burgess, and J.S. Turpin-Mair Fluoride release and recharge of fluoride releasing restorative materials [Abstract 431] J Dent Res 78 1999 159
78. L. Forsten, and I.K. Paunio Fluoride release by silicate cements and resin composites Scand J Dent Res 80 1972 515 519
79. J.O. Burgess, B.K. Norling, and J.B. Summitt Resin ionomer restorative materials: the new generation J Esthet Dent 6 1994 207 215
80. L. Burkett, J.O. Burgess, and D.C.N. Chan Fluoride release of glass ionomers coated and not coated with adhesive [Abstract 1242] J Dent Res 72 1993 258
81. A. Halgreen, A. Oliveby, and S. Twetman Fluoride concentration in plaque adjacent to orthodontic appliances retained with glass ionomer cement Caries Res 27 1993 51 54
82. R.W. Phillips, and M.L. Swartz Effect of certain restorative materials on the solubility of enamel J Am Dent Assoc 54 1957 623 626
83. D. Tantibironj, W.H. Douglas, and A. Versluis Inhibitive effect of a resin modified glass ionomer cement on remote artificial caries Caries Res 31 1997 275 280
84. S. Hatibovic-Hofman, and G. Koch Fluoride release from glass ionomer cement in-vivo and in-vitro Swed Dent J 15 1991 253 258
85. A.N. Alvarez, J.O. Burgess, and D.C.N. Chan Short-term fluoride release of six ionomers - recharged, coated and abraded [Abstract 260] J Dent Res 73 1994 134
86. M. Cranfield, A. Kuhn, and G.B. Winter Factors relating to the rate of fluoride release from glass ionomer cement J Dent 10 1982 333 341
87. J.J.M. Daamen, M.J. Buijs, and J.M. ten Cate Uptake and release of fluoride by saliva coated glass ionomer cement Caries Res 30 1996 454 457
88. W.A. El-Badrawy, and D. McComb Effect of home use fluoride gels on resin modified glass ionomer cement Oper Dent 23 1998 2 9
89. L. Forsten Short-term and long-term fluoride release from glass ionomer and other fluoride containing materials in-vitro Scand J Dent Res 98 1990 179 185